Literature DB >> 22079848

Pancreatic stump-closed pancreaticojejunostomy can be performed safely in normal soft pancreas cases.

Chen Liu1, Jiang Long, Liang Liu, Jin Xu, Bo Zhang, Xianjun Yu, Quanxing Ni.   

Abstract

BACKGROUND: Pancreatic anastomotic failure remains the main reason for morbidity and mortality after pancreaticoduodenectomy, and there is no existing flawless pancreaticojejunal reconstruction approach to this date, especially for the normal soft pancreas cases.
METHODS: We compared a pancreatic stump-closed pancreaticojejunostomy technique (group B; n = 33) with conventional duct-to-mucosa fashion (group A; n = 30) retrospectively in 63 normal soft pancreatic texture cases. Some operative related data including postoperative complications, anastomosis time, hospital stay days, mortality rate, and relaparotomy rate were analyzed.
RESULTS: There was no difference concerning the incidences of postoperative morbidity, including pancreatic fistula, postpancreatectomy hemorrhage, delayed gastric emptying, intra-abdominal abscess, and remnant pancreatitis between two groups. The differences of anastomosis time, hospitalization days, relaparotomy rate, and mortality rate were also not significant. However, group B patients had a shorter duration (d) for healing of postoperative pancreatic fistula than group A (15.3 ± 8.5 versus 33.0 ± 14.1 d, P < 0.05).
CONCLUSION: For the normal soft pancreas cases, pancreatic stump-closed pancreaticojejunostomy technique is quite safe and convenient according to our experience; ideal clinical results could be achieved with its application in the future.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22079848     DOI: 10.1016/j.jss.2011.09.002

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  8 in total

1.  Roux-en-Y pancreaticojejunostomy reconstruction after deep enucleation of benign or borderline pancreatic lesions: a single-institution experience.

Authors:  Zhiwen Xiao; Guopei Luo; Zuqiang Liu; Kaizhou Jin; Jin Xu; Chen Liu; Liang Liu; Quanxing Ni; Jiang Long; Xianjun Yu
Journal:  HPB (Oxford)       Date:  2015-11-17       Impact factor: 3.647

2.  Which patients with resectable pancreatic cancer truly benefit from oncological resection: is it destiny or biology?

Authors:  Lei Zheng; Christopher L Wolfgang
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

3.  Application of "papillary-like main pancreatic duct invaginated" pancreaticojejunostomy for normal soft pancreas cases.

Authors:  Bo Zhang; Jin Xu; Chen Liu; Jiang Long; Liang Liu; Yongfeng Xu; Chuntao Wu; Guopei Luo; Quanxing Ni; Min Li; Xianjun Yu
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

4.  Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL.

Authors:  Jin-Feng Xiang; Wen-Quan Wang; Liang Liu; Hua-Xiang Xu; Chun-Tao Wu; Jing-Xuan Yang; Zi-Hao Qi; Ya-Qi Wang; Jin Xu; Chen Liu; Jiang Long; Quan-Xing Ni; Min Li; Xian-Jun Yu
Journal:  Sci Rep       Date:  2016-01-12       Impact factor: 4.379

5.  An intuitive method of duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy: use of one-step circumferential interrupted sutures.

Authors:  Moonwhan Kim; Woo Young Shin; Keon-Young Lee; Seung-Ik Ahn
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2017-02-28

6.  Pancreatic stump closure after pancreatoduodenectomy in elderly patients: a retrospective clinical study.

Authors:  Claudio Mauriello; Andrea Polistena; Claudio Gambardella; Ernesto Tartaglia; Michele Orditura; Ferdinando De Vita; Luigi Santini; Nicola Avenia; Giovanni Conzo
Journal:  Aging Clin Exp Res       Date:  2016-11-11       Impact factor: 3.636

7.  Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer.

Authors:  Wen-Quan Wang; Liang Liu; Hua-Xiang Xu; Guo-Pei Luo; Tao Chen; Chun-Tao Wu; Yong-Feng Xu; Jin Xu; Chen Liu; Bo Zhang; Jiang Long; Zhao-You Tang; Xian-Jun Yu
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

8.  Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis.

Authors:  Wantong Yao; Shunrong Ji; Yi Qin; Jingxuan Yang; Jin Xu; Bo Zhang; Wenyan Xu; Jiang Liu; Si Shi; Liang Liu; Chen Liu; Jiang Long; Quanxing Ni; Min Li; Xianjun Yu
Journal:  Mol Cancer       Date:  2014-08-07       Impact factor: 27.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.